No Picture
News

GenFleet Therapeutics Announces Broad-spectrum Activity of GFH547, an Oral panRAS (ON) Inhibitor, and Its Potential to Overcome Resistance against SIIP-based KRAS Inhibitors in Late-breaking Research Abstract of 2024 AACR Annual Meeting

SHANGHAI and SAN DIEGO, April 9, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the latest findings of GFH547, an oral panRAS (ON) inhibitor, […]

No Picture
Biotech Networks Trending News

Lundbeck to Present Data on Migraine Impact Reduction and Sustained Response with VYEPTI® (eptinezumab-jjmr) at 76th Annual Meeting of the American Academy of Neurology

DEERFIELD, Ill.–(BUSINESS WIRE)–Lundbeck to Present Data on Migraine Impact Reduction and Sustained Response with VYEPTI at 76th Annual Meeting of the American Academy of Neurology Click here to view original post Click Here to Publish/Feature […]

No Picture
Boston Cambridge Biotech Trending News

Former bluebird execs hope to fly new startup to ‘cutting edge’ of gene therapy delivery tech

The untapped potential of gene editing therapies comes down to one major challenge: getting gene editors safely and efficiently into cells. Now, a startup founded by two genetic medicine luminaries and run by former executives […]

News

Raleigh pharma weighs divesting commercial operations

A year after divesting its top revenue-generating product, RedHill Biopharma is in discussions regarding the potential divestment of more company assets. Click here to view original post Click Here to Publish/Feature Your Company or Product […]